
Projects
NeuroMet - Innovative measurements for improved diagnosis and management of neurodegenerative diseases
Period: | 7/2016 - 6/2019 |
Funding: | EMPIR |
Partners: | LGC Limited (UK), Instituto Nazionale di Ricerca Metrologica (I), Laboratoire National d’Essais (F), SP Sveriges Tekniska Forskningsinstitut AB (S), NeuroCure Clinical Research Centre, University Medicine Charité (D), Laboratory of Biochemistry-Clinical Laboratory, Centre Hospitalier Universitaire de Montpellier (F),National Amyloid Centre and Wolfson Drug Discovery, University College London (UK), School of Nursing at the University of East Anglia (UK) |
Contact: | 8.12, Bernd Ittermann |
This project will combine for the first time the diverse and unique expertise of a number of national measurement institutes together with clinicians and academics to overcome specific metrological barriers in neurodegenerative disease (NDD) diagnosis and treatment with routes to implement this back into the clinic. The project outcomes will contribute to establishing the metrological infrastructure needed to a) facilitate NDD earlier stage diagnosis, b) track disease progression, c) monitor success of drug therapeutic clinical trials and d) monitor response to intervention to improve quality of life.
Together with Charité, PTB will contribute by quantifying imaging and molecular biomarkers in vivo using ultrahigh field MR technology.
More information: here
MRgRT - Metrology for MR guided RadioTherapy
MRgRT - Metrology for MR guided RadioTherapy
Period: | 2016 - 2019 |
Funding: | EMPIR |
Partners: | VSL (NL), Commissariat à l'énergie atomique et aux énergies alternatives (F), NPL (UK), Physikalisch-Technische Bundesanstalt (6.2, 8.1), Deutsches Krebsforschungszentrum (D), Universitair Medisch Centrum Utrecht (NL), The University of Manchester (UK), The Christie NHS Foundation Trust (UK), Eidgenössisches Institut für Metrologie METAS (CH) |
Contact: | 8.11, Frank Seifert |
Cancer patients are treated with radiotherapy in which a high dose of ionizing radiation is used to target and kill cancerous cells. MR-guided radiotherapy, the simultaneous use of Magnetic Resonance (MR)-imaging and Megavolt (MV) photon irradiation allows to see what you treat, and will lead to a step change in radiotherapy the coming years. Improved metrology in dosimetry and imaging for the safe clinical implementation and to support future innovations in MR guided radiotherapy is of great importance.
A special problem of MR-guided radiotherapy in presence of intra-fractional anatomy changes consists of inner organ landmark tracking by real-time MR imaging. Before utilization in radiotherapy the robustness and reliability of such MR procedures must be independently assessed and verified. It was shown previously [24] that the synergetic use of multi-channel UWB radar and MRI is capable of gaining complementary information to reduce uncertainties and to improve reliability of inner organ landmark tracking. The project will go beyond state of the art by using the technique in MR-guided radiotherapy and will overcome the challenges to process the UWB radar data and to fuse them with the MRI information in real-time.
More information: here
BioCog - Biomarker development for postoperative cognitive impairment in the elderly
BioCog - Biomarker development for postoperative cognitive impairment in the elderly
Period: | 8/2014 - 2/2019 |
Funding: | EU |
Partners: | 12 international partners |
Contact: | 8.12, Bernd Ittermann |
Major surgery in elderly patients (> 65 years) often leads to major short-term cognitive disturbance (postoperative delirium, POD), with an associated tendency to increased vulnerability to late-life dementia. In the framework of a large study on 800 subjects, PTB will carry out MR spectroscopy and resting-state fMRI at 7 T in order to identify biomarkers for this vulnerability. A novel image-based technique will be established to quantify the Nucelus basalis Meynert, one of the cholinergic nuclei relevant to neurodegeneration.
More information: here
TRAINSTIM - Neuronal basis of active aging
TRAINSTIM - Neuronal basis of active aging
Period: | 7/2015 - 12/2018 |
Funding: | BMBF |
Partners: | Charité - Universitätsmedizin Berlin, TU Dresden |
Contact: | 8.12, Bernd Ittermann |
Subproject: Study of the age dependence of the effects of transcranial direct current stimulation on GABA concentration and resting-state brain connectivity
The effects of transcranial direct current stimulation (tDCS) on neurotransmitter concentrations and resting-state brain connectivity are studied. GABA and glutamate in healthy subjects from three age groups are determined using MR spectroscopy before and after intervention whilst during intervention resting-state fMRI data are acquired. MEGA-PRESS is used for MRS, wheras resting-state connectivity is measured using Eigenvector Centrality Mapping and FSL.
More information: here
Model-based image reconstruction for fast and accurate T1-mapping of the heart
Model-based image reconstruction for fast and accurate T1-mapping of the heart
Period: | 2015 - 2018 |
Funding: | EMPIR |
Partners: | Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin |
Contact: | 8.13, Christoph Kolbitsch |
Development of novel motion-compensated T1-mapping approaches which utilise signal models during image reconstruction in order to provide accurate T1 maps in the shortest possible scan time. The close collaboration with our clinical partners at the Charité Berlin allows for a quick translation of novel techniques into clinical practice to benefit patient care as soon and as effective as possible.
More information: here
3He-129Xe nuclear spin co-magnetometer used in ultra-low magnetic fields in search of an electric dipole moment of xenon
3He-129Xe nuclear spin co-magnetometer used in ultra-low magnetic fields in search of an electric dipole moment of xenon
Period: | 2010 - 2016 |
Funding: | DFG |
Partners: | Dep 8.2, Dep 8.4, Technische Universität München, University of Michigan, Michigan State University |
Contact: | 8.11, Wolfgang Kilian |
The priority program aims to find answers to fundamental questions of modern particle physics and astrophysics by means of experiments with slow and ultra-cold neutrons. These questions encompass the understanding of natural forces and the associate symmetries and investigations on the gravitational force at very small intervals. In this context, PTB deals with the sub-project "Development of a procedure to optimize magnetic shielding for spin precession experiments like nEDM". Within the scope of this sub-project, a portable magnetically shielded room with a residual magnetic field of < 700 picoteslas and a field gradient of less than 300 pT/m was put into operation in 2015. In the magnetically shielded rooms of PTB in Berlin and of the Technical University of Munich (TU München), precision measurements of the free precession of highly polarized nuclear spins of rare gases are to be carried out in search of an electric dipole moment in the xenon nucleus. In addition to the work on the apparatus, data analysis is an important field of work to enable consistently stating the uncertainties of the upper limits to be determined from the measurements. Such experiments in the range of extremely low energies are expected to provide new insights into fundamental physics.
129Xe 3He comagnetometer in a magnetically shielded room (Helmholtz coils, Dewar with SQUIDs, sphere with the gases 129Xe and 3He)
More informationen: here
T1MES - T1 mapping quality assurance
T1MES - T1 mapping quality assurance
Period: | 2014 - 2017 |
Partners: | Asnières sur Seine - PERTIMM, Bergen - NNL, Berlin- Charité, Berlin - PTB, Bonn - DRZE, Brighton - University of Sussex, Cambridge - University of Cambridge, Dresden - Technische Universität Dresden, Dublin - TCD, Evry - CNG, Hamburg - UKE, London - Delosis, London - IoP, Mannheim - CIMH, Munich - GABO:mi, Nottingham - UNOTT, Orsay - CEA, Orsay - INSERM, Paris - SCITO |
Contact: | 8.12, Rüdiger Brühl |
A collaboration consisting of a specialist MRI enterprise, clinicians, physicists, and national metrology institutes was formed in order to develop a phantom-based quality assurance system for verification of T1-measurement stability over time at individual sites. A phantom was designed and produced (by http://www.resonancehealth.com) covering clinically relevant ranges of T1 and T2 in blood and myocardium. At 16 sites the phantoms are regularly scanned using different T1-mapping sequences and hardware, leading to a dataset for quality assessment and standardization.
Non-cryogenic concentrating of hyperpolarized 129Xe in a continuous gas flow
Non-cryogenic concentrating of hyperpolarized 129Xe in a continuous gas flow
Period: | since 2013 |
Partners: | Helmholtz-Zentrum Geesthacht |
Contact: | 8.11, Wolfgang Kilian |
Using hyperpolarized 129Xe gas in magnetic resonance imaging has enjoyed growing popularity in the past few years, both for use in animal models and in applications for humans. The natural occurrence of xenon in the atmosphere and the possibility of generating signals not only from the gas phase, but also dissolved in the body have contributed to this gain in popularity. The standard procedure to obtain hyperpolarization, however, requires the use of a gas mixture with a comparatively small xenon partial pressure. To date, the hyperpolarized xenon has mostly been separated from the process gases by cryogenic freezing. This procedure is complicated and makes it very difficult to obtain a continuous supply of hyperpolarized 129Xe. By using semipermeable gas-separating membranes, we want to try and eliminate these disadvantages in order to provide a continuous gas flow of highly polarized xenon gas without active control elements and in a high concentration at the place of use.
Gas separation module to concentrate hyperpolarized 129Xe in a continuous gas flow
More informationen: here
IMAGEN - A European study on mental health in teenagers
IMAGEN - A European study on mental health in teenagers
Period: | 2007 - 2018 |
Funding: | EU |
Partners: | IMAGEN consortium, Charité - Universitätsmedizin Berlin |
Contact: | 8.12, Rüdiger Brühl |
The first sub-project examined 14-year-olds and their family background within the scope of a European study. This study consisted in examining approx. 2000 young people at eight research centers (London, Nottingham, Dublin, Berlin, Hamburg, Mannheim, Paris, Dresden). The objective was to be able to make statements on the mental health and on the behavior in relation with risk factors (such as drugs, gambling, etc.) and to correlate these with independent measurement methods such as MRI and genetic analysis. This examination consisted of surveys, psychological tests, genetic investigations and a 2-hour MRI investigation program using fMRI, DTI and anatomic imaging. By repeating this examination on the same volunteers at the age of 18 and 21 years, valuable data on their development was obtained.
More information: here
LeAD – MR spectroscopic correlates of learning during alcohol withdrawal
LeAD – MR spectroscopic correlates of learning during alcohol withdrawal
Period: | 5/2013 - 12/2016 |
Funding: | DFG |
Partners: | Charité - Universitätsmedizin Berlin, MPI für Bildungsforschung |
Contact: | 8.12, Bernd Ittermann |
The project is part of Research Group “Learning & habitization as predictors of the development & maintenance of alcoholism”. The impact of the dopamine x glutamate interaction on learning deficits and consecutive relapse probability is targeted with[18F]fallypride PET (Charité) and the measurement of absolute concentrations of glutamate with MRS (PTB).
Metabolite determination in hippocampus (segmented using FreeSurfer) with LCModel. CRLB – Cramér-Rao Lower Bounds, a measure of fit uncertainty
Dosimetrie mit Alanin für die MR-geführte Strahlentherapie
Dosimetrie mit Alanin für die MR-geführte Strahlentherapie
Zeitraum: | 2016 - 2017 |
Förderung: | DFG |
Partner: | FB 6.2, DKFZ Heidelberg |
Kontakt: | FB 6.2, Franziska Renner |
Bei modernen Methoden der externen Strahlentherapie mit Beschleunigern müssen die Bestrahlungsparameter so gewählt werden, dass eine möglichst große Wirkung im Tumorgebiet erzielt und gleichzeitig umliegendes, gesundes Gewebe optimal geschont wird. Dies wird erst durch den Einsatz bildgebender Verfahren möglich, wobei Bildgebung und Bestrahlung bisher sequenziell mit getrennten Geräten erfolgen. Eine Steigerungsform dessen stellt die Kombination eines bildgebenden Verfahrens, wie z.B. der MRT, mit einem Linearbeschleuniger in einem Gerät dar. Solche MR-Linac-Geräte erlauben es, auf zeitliche Änderungen der Anatomie einzugehen, bis hin zu einer Anpassung der Bestrahlung in Echtzeit (4-D). Dieser neue Entwicklungsschritt in der Strahlentherapie kann nicht nur die Erfolgschancen der Therapie in bestehenden Anwendungsfeldern erhöhen, sondern auch neue Anwendungsgebiete erschließen, z.B. bei der Therapie von Tumoren, die sich aufgrund von Atmung oder Herzschlag stark bewegen. Andererseits stellt die Zusammenführung zweier hochkomplexer Methoden auch vor eine Reihe neuer Herausforderungen im Bereich der Medizinphysik und -technik. Ein Aspekt ist hierbei die qualitätsgesicherte Dosimetrie im Strahlungsfeld eines MR-Linac-Gerätes. Zentrale Idee des vorliegenden Projekts ist es, die Eignung der Alanin-Elektronenspinresonanz für die qualitätsgesicherte Dosimetrie im Strahlungsfeld von kombinierten MR-Linac-Geräten zu untersuchen. Parallel dazu wird die Entwicklung eines MR-kompatiblen Sekundärnormals auf Alaninbasis vorangetrieben.
Weitere Informationen: hier
Metrology for next-generation safety standards and equipment in MRI safety
Metrology for next-generation safety standards and equipment in MRI safety
Period: | 2012 - 2015 |
Funding: | EMRP |
Partners: | Istituto Nazionale di Ricerca Metrologica (INRIM), Torino, Italy; VSL B.V., Delft, Netherlands; King's College London, London, UK |
Contact: | 8.1, Bernd Ittermann |
The goal of this research project is to promote the safe use of MRI by providing the metrological underpinning for future safety standards and regulations. Specific topics of interest are:
- The distribution of radio-frequency electromagnetic fields within the human body
- Induced effects due to movements in the stray magnetic field of an MRI scanner
- Emerging technologies 1: "Ultrahigh" magnetic field strengths and parallel transmission
- Emerging technologies 2: Photon dosimetry for an MRI-accelerator combination
- Metallic implants
More information: here
Mechanisms of anodal direct current stimulation in patients with recurrent brain injury
Mechanisms of anodal direct current stimulation in patients with recurrent brain injury
Period: | 1/2013 - 9/2015 |
Funding: | DFG - "Mechanisms of anodal direct current stimulation in patients with recurrent brain injury - a multimodal analysis using electrophysiology, MR spectroscopy and functional MRI" (FL 379/11-1) |
Partners: | Charité - Universitätsmedizin Berlin |
Contact: | 8.12, Bernd Ittermann |
Using MR spectroscopy, it was tested whether GABA increases in the brain of patients who underwent recurrent traumatic brain injury. As GABAergic activity can be modulated by transcranial direct current stimulation (tDCS) in a polarization-dependent manner, a normalization of GABA was expected in these patients. In addition, transcranial magnetic stimulation was used to indirectly detect changed GABA levels, and correlational analyses served to detect an association of decreased GABA with learning success in behavioral paradigms, and cortical plasticity.
The effect of atDCS on GABA concentration and functional connectivity is studied in two seperate sessions (atDCS vs. sham). T1 = T1-weighted MRI sequence, MRS = MR spectroscopy, atDCS = anodal transcranial direct current stimulation, fMRT = functional MRI („resting state“ fMRI)
The multisensory mind: From neural mechanisms to cognition
The multisensory mind: From neural mechanisms to cognition
Period: | 5/2014 - 12/2015 |
Funding: | ERC |
Partners: | Charité - Universitätsmedizin Berlin |
Contact: | 8.12, Bernd Ittermann |
A key objective of this project is to examine the relationships of resting GABA concentration in a cortical network comprising primary sensory areas and traditional multisensory regions (e. g. the superior temporal gyrus) to multisensory integration through neural synchronization. To this end localized cortical GABA concentration will be measured in a cortical network using MRS, and correlated to synchronized EEG activity during multisensory processing.
Path analysis reveals that GABA concentration mediates the positive correlation between gamma band oscillations (GBO) and the sound-induced flash illusion (SIFI) rate.
BiOrigin – Metrology for biomolecular origin of disease
BiOrigin – Metrology for biomolecular origin of disease
Period: | 6/2012 – 5/2015 |
Funding: | EMRP |
Partners: | National Physical Laboratory (UK), Joint Research Center (EU), University of Oxford (UK), University of Edinburgh (UK), Freie Universität Berlin (D), Max-Delbrück-Centrum (D), Robert-Koch-Institut (D) |
Contact: | 8.11, Lorenz Mitschang |
This project aimed to systematically investigate the structure/function relation for peptides in their interaction with membranes of microbes or corresponding model systems. The investigations focused on the metrological characterization of antimicrobial substances for medicine. As a result, procedures for the quantification of relevant quantities for the interaction of peptides both with liposomes and with living cells and also strategies for their imaging were developed and established.
More information: here
SHAVE – Anatomically selective MR spectroscopy
SHAVE – Anatomically selective MR spectroscopy
Period: | 2013 - 2015 |
Partners: | Otto-von-Guericke-Universität Magdeburg |
Contact: | 8.1, Bernd Ittermann |
State of the art in quantitative brain MRS is to acquire the signal from a cuboid voxel placed in or around the brain structure of interest. Adaptation of a voxel to the anatomical structure of interest is highly desirable in order to avoid either prohobitively small voxels or large amounts of contaminating tissue. The novel sequence SHAVE (SHAped Voxel Excitation) allows for a two-dimensional anatomically adapted excitation. An added two-shot approach permits localization in the third dimension, including readout at very short echo times, which enables the detection of metabolites having short T2 relaxation.
In vivo MR spectrum acquired from an anatomically shaped, white-matter only voxel (insert) excited using SHAVE (8-channel transmit array). The insert shows the actually excited magnetization (left, with blue background) and the respective target voxel (right, superimposed on a localizer scan).
EARS - Human Perception of Non-Audible Sound
EARS - Human Perception of Non-Audible Sound
Period: | 2012 - 2015 |
Funding: | EMRP |
Partners: | 8.2, 1.6, MPI für Bildungsforschung |
Contact: | 8.12, Rüdiger Brühl |
The project EARS addresses the human perception of non-audible sound. Although the applied frequencies of 8 to 20 Hz and 20 to 24 kHz are considered to be outside the human spectrum they can be sensed at high sound pressure. The brain activity and cognitive performance of 20 volunteers were recorded at different frequencies and sound pressure levels. Standardized use of the measurement modalities MEG and fMRI were made possible due to the collaboration of 4 working groups.
More information: here
Earlier projects
NGFN-Plus - Endophenotyping with spectroscopy: Genetic modulation and treatment response
NGFN-Plus - Endophenotyping with spectroscopy: Genetic modulation and treatment response
Period: | 1/2010 - 8/2012 |
Funding: | DFG |
Partners: | Charité - Universitätsmedizin Berlin, ZIMH Mannheim |
Contact: | 8.12, Bernd Ittermann |
A method for in vivo quantification of brain glutamate developed at PTB was applied in this project. Chronic intake of ethanol is associated with a compensatory up-regulation of glutamatergic neurotransmission. Polymorphisms within the glutamate-associated genes modulate the risk of alcohol intake, dependence, craving and relapse. The goal of the project SP14 of the Integrated Genome Research Network „Genetics of Alcohol Addiction“ in NGFN Plus was to investigate (i) the association of genetic variants with cerebral glutamate concentration measured by MRS, (ii) whether increased glutamate brain levels are predictive for treatment response and (iii) if glutamate concentrations are related to alcohol risk factors for alcohol use in non-dependent probands.
Glutamate spectroscopy: cortical MR spectrum together with phantom spectra of glutamate and glutamine at approximately physiological concentrations. There is little interference of the C4 resonances around 2.35 ppm of the two neurotransmitters, thus permitting a fairly selective determination of glutamate.
More information: here
ultraMEDIS - UWB-Radar als medizinisches Sensorsystem
ultraMEDIS - UWB-Radar als medizinisches Sensorsystem
Zeitraum: | 2007 - 2012 |
Förderung: | DFG |
Partner: | Technische Universität Ilmenau, Universitätsklinikum Jena |
Kontakt: | AG 8.11, Frank Seifert |
Das interdisziplinäre Forschungsvorhaben ultraMEDIS, das innerhalb des DFG-Schwerpunktprogramms 1202 "Ultrabreitband-Funktechniken für Kommunikation, Lokalisierung und Sensorik" (UKoLoS) angesiedelt war, zielte auf die Nutzung der Ultrabreitband-Radartechnik (UWB-Radar, Bandbreite 1-10 GHz) für biomedizinische Anwendungen. Dabei nutzt man die hohe zeitliche und räumliche Auflösung der Radarsensoren, deren Kompatibilität zu Schmalbandsystemen sowie die geringe Leistung der Sondierungssignale einschließlich deren Fähigkeit zur Objektdurchdringung. Gerade letztere Eigenschaft macht das UWB-Radar sehr attraktiv für Anwendungen in der Medizin.
Weitere Informationen: hier
INUMAC - Imaging of neuro disease using high field MR and contrastopheres
INUMAC - Imaging of neuro disease using high field MR and contrastopheres
Zeitraum: | 2008 - 2011 |
Förderung: | BMBF |
Partner: | Bruker BioSpin MRI GmbH, Albert-Ludwigs-Universität Freiburg |
Kontakt: | AG 8.11, Frank Seifert |
Ziel des INUMAC-Konsortiums war die Erforschung von Hochfeld-Magnetresonanztomographie-Verfahren und neuen zielgerichteten Kontrastmitteln, die für die Diagnostik neurologischer Erkrankungen geeignet sind. Das Projekt war in drei Arbeitspakete gegliedert:
- Untersuchung innovativer Technologien zur verbesserten Sensitivität, räumlichen, zeitlichen und spektralen Auflösung von klinischen MR-Systemen anhand von Forschungs- und Entwicklungsarbeiten für ein Ganzkörper-Ultrahochfeld-MRT mit 11,7 Tesla.
- Evaluierung neuer Ansätze und Konzepte für verschiedene kritische MR-Systemkomponenten, wie neue Gradientenkonzepte, parallele Bildgebung und Echtzeit-Meßverfahren.
- Forschung und präklinische Entwicklung neuartiger zielgerichteter Kontrastmittel für die Diagnose der Alzheimer-Krankheit, von Gehirntumoren und Schlaganfall.
Weitere Informationen: hier
Entwicklung und Implementation von Messverfahren zur SAR-Bestimmung an Probenköpfen für die Hochfeld-MRT
Entwicklung und Implementation von Messverfahren zur SAR-Bestimmung an Probenköpfen für die Hochfeld-MRT
Zeitraum: | 2008 - 2011 |
Förderung: | BMWi |
Partner: | Rapid Biomedical GmbH |
Kontakt: | FB 8.1, Bernd Ittermann |
Ziel des Projektes war es, bei der Fa. Rapid Biomedical ("Rapid") ein Verfahren zu implementieren, das einen sicheren Betrieb der dort entwickelten Hochfrequenz(HF)-Spulen an MR-Systemen mit hohen Feldstärken (überwiegend 3 T und 7 T) gewährleistet. Diese Sicherheit betrifft insbesondere die SAR-Belastung von Patienten, die in MR-Untersuchungen nicht vermeidbar, aber minimierbar ist. Die gesetzlichen Grenzwerte sind zwar klar definiert, aber nur schwer genau bestimmbar. Hierfür sollte die Kooperation mit der PTB weiterhelfen. Grundsätzliche Konzepte zu dieser Fragestellung existierten an der PTB bereits vor Projektbeginn, waren jedoch nicht unmittelbar in das KMU übertragbar, da sie Zugang zu teuren MRT-Scannern und weiterem High-End-Equipment voraussetzten. Die Erarbeitung einer kostengünstigen und aufgabenangepassten Implementierung dieser Verfahren bei Rapid war eine zentrale Aufgabenstellung des Projekts.
3He 129Xe nuclear spin co-magnetometer in ultra-low magnetic fields in search of a Lorentz invariance violation and of new pseudo-scalar bosons (axion-like particles)
3He 129Xe nuclear spin co-magnetometer in ultra-low magnetic fields in search of a Lorentz invariance violation and of new pseudo-scalar bosons (axion-like particles)
Period: | 2008 - 2013 |
Partners: | Dep 8.2, Universität Mainz, Universität Heidelberg |
Contact: | 8.11, Wolfgang Kilian |
Due to the very long coherence times, the simultaneous and free precession of highly polarized nuclear spins of rare gases in ultra-low, highly homogeneous magnetic fields allows very long measurement times (from several hours to several days) and, thus, an extremely high frequency resolution. By using two sorts of atoms, this procedure represents a kind of clock comparison which allows influences due to magnetic field variations to be eliminated and, thus, enables the search for hypothetical effects which are postulated by theories beyond the standard model of particle physics. In this project, the existing upper limits were lowered for both interactions which lead to Lorentz invariance violation and which would generate the short-range spin/mass interaction (mediated by pseudo-scalar bosons).
Innovation competition in medical engineering: Biosensor-based 129Xe magnetic resonance tomography in cells and mouse models of autoimmunity
Innovation competition in medical engineering: Biosensor-based 129Xe magnetic resonance tomography in cells and mouse models of autoimmunity
Period: | 5/2010 – 11/2013 |
Funding: | BMBF |
Partners: | Leibniz Institut für Molekulare Pharmakologie, Freie Universität Berlin |
Contact: | 8.11, Lorenz Mitschang |
The joint research project directed by PTB aimed to develop a technology of molecular imaging of immunologically relevant systems by using hyperpolarized 129Xe in MRI. For this purpose, a mobile polarizer for use in animal imaging (external lab) and an animal ventilator for mice or rats were developed and manufactured, and the fundamental mechanisms of the interaction of hyperpolarized 129Xe with binding substances (contrast agents) relevant to molecular imaging were elucidated.
Representation and manufactured mobile xenon polarizer
Cooperations
Berliner Ultrahochfeld-Facility
Berliner Ultrahochfeld-Facility
Zeitraum: | seit 2009 |
Förderung: | BMBF |
Partner: | Max-Delbrück-Centrum für Molekulare Medizin |
Kontakt: | FB 8.1, Bernd Ittermann |
Die Berliner Ultrahochfeld Facility (BUFF) wurde von einem Konsortium Berliner Forschungseinrichtungen unter Führung des Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch auf dem MDC-Campus errichtet. Kernstücke der neuen Einrichtung waren zunächst ein 7-Tesla-Ganzkörper-MRT für die klinische Forschung und ein 9,4-Tesla-MRT für Untersuchungen an Kleintieren.
Weitere Informationen: hier
European network for hyperpolarization physics and methodology in NMR and MRI
European network for hyperpolarization physics and methodology in NMR and MRI
Period: | 10/2010 - 10/2015 |
Funding: | EU |
Partners: | Members of EUROHyperPOL |
Contact: | 8.11, Wolfgang Kilian |
Nuclear magnetic resonance (NMR) spectroscopy, microscopy and imaging techniques (MRI) play a crucial role in numerous fields of science ranging from physics, chemistry, and material sciences to biology and medicine. However, despite all their versatility, a common key issue is sensitivity, which limits the applicability of NMR spectroscopy and imaging techniques in the case of fast dynamic processes and detection of low concentrated molecules in both in vitro and in vivo applications. The action aims to stimulate and accelerate collaborations and joint research efforts between European groups into hyperpolarization physics and methodology with the goal to develop robust strategies for sensitivity enhancement in NMR and MRI.
More information: here
Imaging-Netzwerk Berlin
Imaging-Netzwerk Berlin
Zeitraum: | seit 2006 |
Partner: | Berlin Partner für Wirtschaft und Technologie GmbH |
Kontakt: | FB 8.1, Bernd Ittermann |
Das Imaging Netzwerk Berlin (INB) hat das Ziel, die Zusammenführung und Koordination der verteilten Aktivitäten im Bereich der medizinischen Bildgebung voranzutreiben und mögliche Lücken im Wertschöpfungsprozess zu schließen. Das Imaging Netzwerk Berlin (INB) ist als offenes Netzwerk konzipiert, in dem neue Partner willkommen sind. Seit 2012 ist es bundesweit für neue Mitglieder geöffnet.
Weitere Informationen: hier
GUFI - German ultrahigh field imaging
GUFI - German ultrahigh field imaging
Zeitraum: | 2013 - 2016 |
Förderung: | DFG |
Partner: | BUFF, Berlin; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn; Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen; Universitätsklinik Freiburg; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg; Forschungszentrum Jülich; Max-Planck-Institut für Kognitions- und Neurowissenschaften, Leipzig; Leibniz-Institut für Neurobiologie und Otto-von-Guericke Universität Magdeburg, Magdeburg; Max-Planck-Institut für biologische Kybernetik, Tübingen; Deutsches Zentrum für Herzinsuffizienz (DZHI), Würzburg |
Kontakt: | FB 8.1, Bernd Ittermann |
Innerhalb der vergangenen Jahre wurden in Deutschland sieben Zentren für humane Ultrahochfeld(UHF)-MR-Bildgebung eingerichtet. Um diese hochkomplexe Technologie einer größeren Anzahl von Forschern zugänglich zu machen, bedarf es einer Zusammenarbeit der UHF-MR-Zentren. Zur Erlangung dieses Ziels haben alle deutschen UHF-Zentren beschlossen, ein nationales Netzwerk mit dem Namen German Ultrahigh Field Imaging (GUFI) zu etablieren. Dreizehn Standorte gehören derzeit zu GUFI. Weitere UHF-Einrichtungen sind herzlich eingeladen, sich dem GUFI-Netzwerk anzuschließen. Dieses Projekt wird im Rahmen der Förderung „Gerätezentren – Core Facilities“ von der Deutschen Forschungsgemeinschaft (DFG), Fördernummer: LA 1325/5-1, gefördert.
Weitere Informationen: hier
Contact
Head of Department
Dr. Bernd Ittermann
Phone: +49 30 3481-7318
Email:
bernd.ittermann(at)ptb.de
Secretariat
Karin Müller
Phone: +49 30 3481-7303
Email:
karin.mueller(at)ptb.de
Address
Physikalisch-Technische Bundesanstalt
Abbestraße 2–12
10587 Berlin